ライフサイエンスコーパス: mesenteric vein

1 genous insulin replacement into the superior mesenteric vein.

2 ough a Hickman line inserted in the inferior mesenteric vein.

3 utflow by a proximal segment of the superior mesenteric vein.

4 tumor, normal pancreas, aorta, and superior mesenteric vein.

5 eric artery and a catheter into the superior mesenteric vein.

6 ent with a stent extending into the superior mesenteric vein.

7 portal vein in continuity with the inferior mesenteric vein.

8 o the confluence of the splenic and superior mesenteric veins.

9 ary tumor (98%), portal vein (97%), superior mesenteric vein (94%), hepatic artery (93%), and superio

10 invasion, and flow artifacts in the superior mesenteric vein and measured attenuation of tumor, norma

11 omputerized tomographic scan showed superior mesenteric vein and portal vein thrombosis.

12 , and diameter of main portal vein, superior mesenteric vein, and splenic vein.

13 third-order branching; 17 (85%) in superior mesenteric veins; and 17 (85%) in portal veins.

14 Glucosensory elements in the portal-mesenteric veins are dispensable with faster rates when

15 at the tail of the pancreas and the superior mesenteric vein at the level of the mesentery or head of

16 colonic ischemia, the presence of gas in the mesenteric veins but not in the portal vein.

17 ts and decreased attenuation in the superior mesenteric vein, compared with the artifacts revealed on

18 ze with abutment of the portal vein-superior mesenteric vein confluence for less than 180 degrees .

19 ely to have a difficult portal vein/superior mesenteric vein dissection when compared to the PA patie

20 in in all but one case in which the inferior mesenteric vein drained into the splenic vein.

21 vein (three of four patients), and superior mesenteric vein (five of five patients).

22 Superior mesenteric vein flow increased from 119 +/- 66 mL/min be

23 inferior mesenteric artery (IMA) or inferior mesenteric vein (IMV) in vitro to identify ganglionic ne

24 Inferior mesenteric vein (IMV) was harvested from patients underg

25 erior mesenteric vein (SMV), in 37; inferior mesenteric vein (IMV), in 35; posterior superior pancrea

26 eric artery and a catheter into the superior mesenteric vein in 21 female pigs.

27 ection was at or to the left of the superior mesenteric vein in 96% of patients.

28 d the confluence of the splenic and superior mesenteric veins in 21 (60%) and 11 (31%) patients, resp

29 In the intact rat, a mesenteric vein infusion of lipopolysaccharide (LPS) ser

30 tomy, a second-order tributary branch of the mesenteric vein is cannulated to provide endovascular ac

31 Twenty-two of 25 superior mesenteric vein, main portal vein, and right and left po

32 The superior and inferior mesenteric veins merged to become the portal vein in all

33 rior vena cava (n = 10), portal and superior mesenteric veins (n = 7), splenic vein (n = 4), and aort

34 lized in vivo, lining the lumen of activated mesenteric veins of Adamts13(-/-) mice.

35 histosoma mansoni blood flukes reside in the mesenteric veins of their vertebrate hosts, where they a

36 Tumor adherence to the superior mesenteric vein or SMPV confluence was assessed intraope

37 ceptor 7/8 (TLR7/8)-mediated inflammation of mesenteric veins, platelet activation drives the rapid m

38 Hypoglycemic detection at the portal-mesenteric vein (PMV) appears mediated by spinal afferen

39 the portal vein (PV) or portal and superior mesenteric veins (PMV) or sham operation (control).

40 ctomy (PD) with en-bloc portal vein/superior mesenteric vein (PV/SMV) resection is used in patients w

41 infusion of lipopolysaccharide (LPS) into a mesenteric vein served as an acute, liver-focused model

42 llograft superior mesenteric artery-superior mesenteric vein (SMA-SMV) AVF in a pancreas-after-kidney

43 evaluated images for two new signs, superior mesenteric vein (SMV) "beaking" and "criss-cross" of the

44 mallest axes (r = -0.39), change in superior mesenteric vein (SMV) and/or portal vein (hereafter, SMV

45 to the liver and atypically located superior mesenteric vein (SMV) joining with the splenic vein to f

46 nodes, four patients; and need for superior mesenteric vein (SMV) resection, four patients).

47 ed in 37; splenic vein (SV), in 37; superior mesenteric vein (SMV), in 37; inferior mesenteric vein (

48 y measurements were obtained in the superior mesenteric vein (SMV), splenic vein (SV), portal vein (P

49 ior mesenteric artery, portal vein, superior mesenteric vein, splenic vein, hepatic veins, and inferi

50 patient had stent migration to the superior mesenteric vein that was removed at the time of DSRS.

51 In mesenteric veins, there was diminished constriction to N

52 ery thromboembolism, 25 (22%) had a superior mesenteric vein thrombosis, and 4 (3%) had superior mese

53 One patient had an isolated superior mesenteric vein thrombus.

54 study was to determine the effectiveness of mesenteric vein to left portal vein bypass operation (ML

55 ycemic detection shifts away from the portal-mesenteric vein to some other loci (e.g., the brain) whe

56 catheter directed under fluoroscopy from the mesenteric vein to the portal vein.

57 tive placement of the stent via the inferior mesenteric vein under fluoroscopic guidance.

58 while one had flow reversal in the superior mesenteric vein visible at MR imaging only.

59 Extension of PVT into the mesenteric veins was significantly more common in the PB